{"id":334059,"date":"2026-10-31T11:14:00","date_gmt":"2026-10-31T05:44:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/sarda-proteins-q2-results-fy27-pat-0-14-crore\/"},"modified":"2026-10-31T11:14:00","modified_gmt":"2026-10-31T05:44:00","slug":"sarda-proteins-q2-results-fy27-pat-0-14-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sarda-proteins-q2-results-fy27-pat-0-14-crore\/","title":{"rendered":"Sarda Proteins Q2 Results FY27: Revenue Drops 81.16% to Rs 0.81 Cr, PAT Rs 0.14 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Sarda Proteins Q2 Results FY27 were declared on 30 October 2026, and the standalone results show revenue of Rs 0.81 Cr, down 81.16% from Rs 4.3 Cr, a negative YoY growth figure. Net profit fell 65% to Rs 0.14 Cr from Rs 0.4 Cr. Operating Profit was Rs 0.19 Cr against Rs 0.3 Cr. These quarterly results cover the July to September 2026 quarter on a Standalone basis.<\/p>\n<\/div>\n

Sarda Proteins Ltd<\/a> (FRESITA) Q2 Results FY27 announced on 30 October 2026, covering the company’s financial performance for the July to September quarter. Revenue was Rs 0.81 Cr and PAT was Rs 0.14 Cr, both lower than a year earlier. In this Sarda Proteins Q2 Results FY27 coverage, the results date and the Standalone results basis set the frame, and each comparison below is made against the same quarter of last year.<\/p>\n

For readers tracking Sarda Proteins Q2 Results, this results analysis from Univest covers the financial highlights, business drivers, outlook and risks, and it begins with the Financial Highlights below.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n